trial

Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic

NCTId NCT02748083
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 49 (actual)
Sponsored by Shanghai Mental Health Center
Primary completion 2017-09-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
49 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2015-12-01
Primary completion
2017-09-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
TDCS

Sponsors

Shanghai Mental Health CenterLead Sponsor
Nathan Kline Institute for Psychiatric ResearchCollaborator

Investigators

1
Chunbo Li, Ph.D.Principal Investigator

Sites

1 total
Shanghai, China

Facts & assertions

4 sourced
Enrollment
49
Phase
NA
Primary Completion Date
2017-09-01
Status
COMPLETED
relationships
The graph out of here
drug
TDCS
drug
lead_sponsor
Shanghai Mental Health Center
company
collaborator
Nathan Kline Institute for Psychiatric Research
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Chunbo Li, Ph.D.
person